Endeavor Biomedicines
PrivateLast Round
Series C
Apr 24, 2024
Total Funding Raised
$295.5M
Company Overview
Endeavor BioMedicines is a biotechnology company focused on developing innovative therapies aimed at addressing the root causes of pulmonary fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endeavor Biomedicines Comps
Public and private peers based on sector, stage, and business model.
Endeavor Biomedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 24, 2024 | ||||
| Series B | Feb 7, 2022 | ||||
| Series A | Jan 7, 2021 |
Key People
Founding team and executive leadership
Endeavor Biomedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series C, Series B, Series A |
| Aberdeen Group | Series C |
| SymBiosis Capital Management | Series C |
| Omega Funds | Series C, Series B, Series A |
| Perceptive Advisors | Series C, Series B |
| abrdn Inc. | Series C |
| Ally Bridge Group | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Two posters accepted for American Thoracic Society 2025 International Conference.
- Apr 2, 2025
Lisa Lancaster, M.D. appointed as new Chief Medical Officer.
Endeavor Biomedicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endeavor Biomedicines's valuation, stock price, and market status.
